- Home
- BEDU vs CYCC Comparison
BEDU vs CYCC Comparison
Compare BEDU & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEDU
- CYCC
- Stock Information
- Founded
- BEDU 1994
- CYCC 1992
- Country
- BEDU United Kingdom
- CYCC Malaysia
- Employees
- BEDU N/A
- CYCC N/A
- Industry
- BEDU Other Consumer Services
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- BEDU Real Estate
- CYCC Health Care
- Exchange
- BEDU Nasdaq
- CYCC Nasdaq
- Market Cap
- BEDU 44.9M
- CYCC 47.6M
- IPO Year
- BEDU 2017
- CYCC N/A
- Fundamental
- Price
- BEDU $1.51
- CYCC $0.25
- Analyst Decision
- BEDU
- CYCC Strong Buy
- Analyst Count
- BEDU 0
- CYCC 1
- Target Price
- BEDU N/A
- CYCC $11.00
- AVG Volume (30 Days)
- BEDU 13.9K
- CYCC 7.3M
- Earning Date
- BEDU 04-28-2025
- CYCC 05-20-2025
- Dividend Yield
- BEDU N/A
- CYCC 59.13%
- EPS Growth
- BEDU N/A
- CYCC N/A
- EPS
- BEDU N/A
- CYCC N/A
- Revenue
- BEDU $224,321,752.00
- CYCC $43,000.00
- Revenue This Year
- BEDU N/A
- CYCC $137.21
- Revenue Next Year
- BEDU N/A
- CYCC N/A
- P/E Ratio
- BEDU N/A
- CYCC N/A
- Revenue Growth
- BEDU N/A
- CYCC N/A
- 52 Week Low
- BEDU $1.35
- CYCC $0.17
- 52 Week High
- BEDU $2.42
- CYCC $3.08
- Technical
- Relative Strength Index (RSI)
- BEDU 42.49
- CYCC 47.06
- Support Level
- BEDU $1.40
- CYCC $0.28
- Resistance Level
- BEDU $1.94
- CYCC $0.37
- Average True Range (ATR)
- BEDU 0.11
- CYCC 0.07
- MACD
- BEDU -0.00
- CYCC 0.01
- Stochastic Oscillator
- BEDU 20.41
- CYCC 20.67
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.